Motivational interviewing for modifying diabetes risk: a randomised controlled trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goldberg, 2006, Lifestyle interventions to prevent type 2 diabetes, Lancet, 368, 1634, 10.1016/S0140-6736(06)69676-1
Miller WR Rollnick S (2002) Motivational interviewing: preparing people for change (Guildford Press, New York, NY), 2nd edn.
Miller, 2004, Motivational interviewing in service to health promotion, Am J Health Promot, 18, A1
Motivational interviewing: MINT trainers Motivational Interviewing Network of Trainers, http://motivationalinterview.org/training/trainers.html (accessed 29 Apr 2008).
Rubak, 2005, Motivational interviewing: a systematic review and meta-analysis, Br J Gen Pract, 55, 305
Department of Health (2004) Choosing health: making healthier choices easier (Department of Health, London).
Wang, 2003, Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor's office, Am J Clin Nutr, 78, 902, 10.1093/ajcn/78.5.902
Kriska, 1997, Introduction to the collection of physical activity questionnaires, Med Sci Sports Exerc, 29, S73, 10.1097/00005768-199706001-00003
Roland, 1998, Understanding controlled trials: what are pragmatic trials?, BMJ, 316, 285, 10.1136/bmj.316.7127.285
Renders CM Renders CM Valk GD (2001) Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev, CD001481.
Avenell, 2004, Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement, Health Technol Assess, 8, iii, 10.3310/hta8210
Evans, 2006, Development of an educational ‘toolkif’ for health professionals and their patients with prediabetes: the WAKEUP study (Ways of Addressing Knowledge Education and Understanding in Pre-diabetes), Diabet Med, 24, 770, 10.1111/j.1464-5491.2007.02130.x
Lindgren, 2007, Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective, Int J Technol Assess Health Care, 23, 177, 10.1017/S0266462307070286
2003, Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes, Diabetes Care, 26, 2518, 10.2337/diacare.26.9.2518
Foxcroft, 2000, Orlistat for the treatment of obesity: rapid review and cost-effectiveness model, Obes Rev, 1, 121, 10.1046/j.1467-789x.2000.00011.x